- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
12
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
12 companies
Lee's Pharmaceutical Holdings
Market Cap: HK$1.1b
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$1.94
7D
0.5%
1Y
57.7%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.20
7D
4.8%
1Y
51.7%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$9.2b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$22.94
7D
0.8%
1Y
232.9%
JBM (Healthcare)
Market Cap: HK$2.4b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.97
7D
3.1%
1Y
197.0%
Medtide
Market Cap: HK$4.3b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$30.60
7D
2.0%
1Y
n/a
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.36
7D
-3.8%
1Y
56.3%
Alphamab Oncology
Market Cap: HK$11.5b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.
9966
HK$11.84
7D
-17.7%
1Y
196.0%
Jacobson Pharma
Market Cap: HK$2.9b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.44
7D
-0.7%
1Y
125.0%
Viva Biotech Holdings
Market Cap: HK$5.1b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$2.43
7D
0.8%
1Y
158.5%
HBM Holdings
Market Cap: HK$10.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$12.44
7D
-2.7%
1Y
864.3%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.3b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.71
7D
-1.2%
1Y
5.1%
Consun Pharmaceutical Group
Market Cap: HK$12.9b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.18
7D
0.7%
1Y
82.9%